Resultaten visas 1 - 10 / 9207
resultat / per sida
Vilka publikationsuppgifter finns i tjänsten?
Publikationens namn
Upphovspersoner
Publikationskanal
År
Publicationer information ikon

Serum cholesterol and prostate cancer risk in the Finnish randomized study of screening for prostate cancer

Referentgranskad
DOI
10.1038/s41391-018-0087-0
Murtola, Teemu J.; Talala, Kirsi; Kasurinen, Tatu V. J.; Taari, Kimmo; Tammela, Teuvo L. J.; Auvinen...
Prostate cancer and prostatic diseases2019Publicationer information ikon

Impact of family history of cancer on risk and mortality of second cancers in patients with prostate cancer

Referentgranskad
DOI
10.1038/s41391-018-0089-y
Chattopadhyay, Subhayan; Hemminki, Otto; Försti, Asta; Sundquist, Kristina; Sundquist, Jan; Hemminki...
Prostate cancer and prostatic diseases2019Publicationer information ikon

Blood glucose, glucose balance, and disease-specific survival after prostate cancer diagnosis in the Finnish Randomized Study of Screening for Prostate Cancer

Referentgranskad
DOI
10.1038/s41391-018-0123-0
Murtola, Teemu J.; Salli, Samueli M.; Talala, Kirsi; Taari, Kimmo; TammelaL, Teuvo L. J.; Auvinen, A...
Prostate cancer and prostatic diseases2019Publicationer information ikon

Allopurinol and prostate cancer survival in a Finnish population-based cohort

Referentgranskad
Öppen tillgång
DOI
10.1038/s41391-022-00597-4
Kukko, Ville; Kaipia, Antti; Talala, Kirsi; Taari, Kimmo; Tammela, Teuvo L. J.; Auvinen, Anssi; Murt...
Prostate cancer and prostatic diseases2022Publicationer information ikon

Allopurinol and the risk of prostate cancer in a Finnish population-based cohort

Referentgranskad
DOI
10.1038/s41391-019-0129-2
Kukko, Ville; Kaipia, Antti; Talala, Kirsi; Taari, Kimmo; Tammela, Teuvo L. J.; Auvinen, Anssi; Murt...
Prostate cancer and prostatic diseases2019Publicationer information ikon

Safety and tolerability of long-term treatment with darolutamide in patients with metastatic castration-resistant prostate cancer

Referentgranskad
Öppen tillgång
DOI
10.1038/s41391-023-00740-9
Jones, Robert Hugh; Fizazi, Karim; James, Nicholas D.; Tammela, Teuvo L.; Matsubara, Nobuaki; Priou,...
Prostate cancer and prostatic diseases2023Publicationer information ikon

Prostate cancer prognosis after initiation of androgen deprivation therapy among statin users: A population-based cohort study

Referentgranskad
Öppen tillgång
DOI
10.1038/s41391-021-00351-2
Peltomaa, A. I.; Raittinen, P.; Talala, K.; Taari, K.; Tammela, T. L. J.; Auvinen, A.; Murtola, T. J...
Prostate cancer and prostatic diseases2021Publicationer information ikon

A high-density tissue microarray from patients with clinically localized prostate cancer reveals ERG and TATI exclusivity in tumor cells

Referentgranskad
DOI
10.1038/pcan.2013.7
Lippolis, G.; Edsjo, A.; Stenman, U-H; Bjartell, A.
Prostate cancer and prostatic diseases2013Publicationer information ikon

Prostate Cancer, Inflammation and Antioxidants

Referentgranskad
DOI
10.5772/53296
Crohns, Marika; Westermarck, Tuomas; Atroshi, Faik
InTech2013Publicationer information ikon

Increase of prostate biopsy-related bacteremic complications in southern Finland, 2005-2013:a population-based analysis

Referentgranskad
DOI
10.1038/pcan.2016.36
Lahdensuo, Maija Kanerva; Rannikko, A.; Anttila, Veli-Jukka A; Erickson, A.; Patari-Sampo, A.; Rauti...
Prostate cancer and prostatic diseases2016

Serum cholesterol and prostate cancer risk in the Finnish randomized study of screening for prostate cancer

Referentgranskad
DOI
10.1038/s41391-018-0087-0
2019

Impact of family history of cancer on risk and mortality of second cancers in patients with prostate cancer

Referentgranskad
DOI
10.1038/s41391-018-0089-y
2019

Blood glucose, glucose balance, and disease-specific survival after prostate cancer diagnosis in the Finnish Randomized Study of Screening for Prostate Cancer

Referentgranskad
DOI
10.1038/s41391-018-0123-0
2019

Allopurinol and prostate cancer survival in a Finnish population-based cohort

Referentgranskad
Öppen tillgång
DOI
10.1038/s41391-022-00597-4
2022

Allopurinol and the risk of prostate cancer in a Finnish population-based cohort

Referentgranskad
DOI
10.1038/s41391-019-0129-2
2019

Safety and tolerability of long-term treatment with darolutamide in patients with metastatic castration-resistant prostate cancer

Referentgranskad
Öppen tillgång
DOI
10.1038/s41391-023-00740-9
2023

Prostate cancer prognosis after initiation of androgen deprivation therapy among statin users: A population-based cohort study

Referentgranskad
Öppen tillgång
DOI
10.1038/s41391-021-00351-2
2021

A high-density tissue microarray from patients with clinically localized prostate cancer reveals ERG and TATI exclusivity in tumor cells

Referentgranskad
DOI
10.1038/pcan.2013.7
2013

Prostate Cancer, Inflammation and Antioxidants

Referentgranskad
DOI
10.5772/53296
2013

Increase of prostate biopsy-related bacteremic complications in southern Finland, 2005-2013:a population-based analysis

Referentgranskad
DOI
10.1038/pcan.2016.36
2016